News | October 11, 2013

Preventice Receives CE Mark for BodyGuardian Remote Monitoring ECG System

European clinical trial interest remains strong; company poised for global distribution

ECG holter remote monitoring patient systems preventice BodyGuardian mayoclinic

October 11, 2013 — Preventice Inc. has received CE mark certification for its BodyGuardian remote monitoring system.

Developed in collaboration with Mayo Clinic, the BodyGuardian uses algorithms to support remote monitoring for individuals with cardiac arrhythmias. The BodyGuardian allows physicians to monitor biometrics outside the clinical setting. A small body sensor attached to the patient's chest collects important data, including the patient's electrocardiogram (ECG), heart rate, respiration rate and activity level. Patient data can then be transmitted to physicians via mobile phone technology.

Preventice received U.S. Food and Drug Administration (FDA) clearance in August 2012 and recently received ISO 13485: 2003 certification.

Jon Otterstatter, co-founder, president and CEO, Preventice, noted that use of remote monitoring technology in healthcare is already on the rise, and that Preventice was named as a leading resource for ECG remote monitoring in the most recent "Hype Cycle for Telemedicine, 2013," from Gartner Research. Gartner analysts noted the potential for remote monitoring technology to improve the patient experience, address the looming shortage in healthcare workers, reduce hospital readmissions and positively impact healthcare trends.

BodyGuardian is supported by the Preventice Care Platform, a cloud-based mHealth Platform that collects real-time data from devices and delivers information to medical monitoring professionals.

For more information: www.mayoclinic.com, www.preventice.com

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Overlay Init